🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes

RecruitingNAAges 18 Years - anyAllGermans Trias i Pujol Hospital
NCT07746258 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is about a type of skin cancer called high-risk cutaneous squamous cell carcinoma (HRcSCC). Although most people with this type of skin cancer are successfully treated, some patients have a higher chance that the cancer will spread to nearby lymph nodes. When this happens, treatment becomes more difficult and the chances of recovery are lower. The aim of this study is to find out whether looking for cancer spread at a very early stage can improve patients' health and survival. The study focuses on the sentinel lymph node, which is the first lymph node that fluid from the skin tumour reaches. If cancer cells begin to spread, this is usually the first place where they are found. By examining this lymph node, doctors may be able to detect cancer spread before it can be seen on scans or felt during a physical examination. A total of 142 participants with high-risk skin cancer w

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patients with HRcSCC according to the criteria established in the following table. Diagnosis of HRcSCC will be made if it complies: * 3 major criteria * 2 major criteria and 2 minor criteria * 1 major criteria and 4 minor criteria. Major clinical criteria: Major histological criteria: 1. Dystrophic epidermolysis ampollosa 2. Epidermodysplasia verruciforme 3. Congenital dyskeratosis Major tumor thickness of 6 mm. 4. Pigmentose xeroderm 5. Oculocutaneous albinism * Immunosuppression by: Perineural invasion Pulmonary transplantation to heart Hematological disease * Location: lip, anogenital, atrial pavilion Bone infiltration * Tumor recurrence * Major tumor diameter of 5 cm. * Sign informed consent Exclusion Criteria: * \- Presence of clinically obvious metastases (N1) * Concomitan pathologies with high risk of lethality. * Concomitan pathologies that contraindicate the test. * Pregnancy * Breastfeeding * T3 or T4 of lip are excluded. These patients will be performed cervical lymphadenectomy by protocol.
💊

What it tests

  • Lymphadenectomy
📍

Where

1 site
Germans Trias i Pujol Universitary Hospital
Badalona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy